BIO-key International Inc (BKYI) Q2 2024 Earnings Call Highlights: Navigating Challenges with ...

GuruFocus.com10-10

Revenue: $1.1 million in Q2 2024, down from $1.9 million in Q2 2023. Gross Margin: Improved to 77% in Q2 2024 from 69% in Q2 2023. Net Loss: $1.7 million, or $1 per share, in Q2 2024, improved from $...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2474785064?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/4HmQLdHpQ1RKhdV7J8lDRg--~B/aD0yOTM7dz0yOTM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/05208175eaea5082697be9a2acf9a0d1","is_english":true,"pubTime":"2024-10-10 06:29","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2474785064","market":"us","top_or_hot":-1,"title":"BIO-key International Inc (BKYI) Q2 2024 Earnings Call Highlights: Navigating Challenges with ...","media":"GuruFocus.com","content":"<div>\n<p>Revenue: $1.1 million in Q2 2024, down from $1.9 million in Q2 2023.\nGross Margin: Improved to 77% in Q2 2024 from 69% in Q2 2023.\nNet Loss: $1.7 million, or $1 per share, in Q2 2024, improved from $...</p>\n\n<a href=\"https://finance.yahoo.com/news/bio-key-international-inc-bkyi-222934552.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BIO-key International Inc (BKYI) Q2 2024 Earnings Call Highlights: Navigating Challenges with ...</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBIO-key International Inc (BKYI) Q2 2024 Earnings Call Highlights: Navigating Challenges with ...\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-10 06:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/bio-key-international-inc-bkyi-222934552.html><strong>GuruFocus.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Revenue: $1.1 million in Q2 2024, down from $1.9 million in Q2 2023.\nGross Margin: Improved to 77% in Q2 2024 from 69% in Q2 2023.\nNet Loss: $1.7 million, or $1 per share, in Q2 2024, improved from $...</p>\n\n<a href=\"https://finance.yahoo.com/news/bio-key-international-inc-bkyi-222934552.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BIO","symbol_name":"Bio Rad实验室","start_time":0,"source_url":"https://finance.yahoo.com/news/bio-key-international-inc-bkyi-222934552.html","article_id":"2474785064","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/4HmQLdHpQ1RKhdV7J8lDRg--~B/aD0yOTM7dz0yOTM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/05208175eaea5082697be9a2acf9a0d1"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2474785064","pubTimestamp":1728512974,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Revenue: $1.1 million in Q2 2024, down from $1.9 million in Q2 2023.Gross Margin: Improved to 77% in Q2 2024 from 69% in Q2 2023.Net Loss: $1.7 million, or $1 per share, in Q2 2024, improved from $2.6 million, or $4.71 per share, in Q2 2023.Operating Expenses: Reduced by $168,000 in Q2 2024 compared to Q2 2023.Cash and Cash Equivalents: $1.3 million as of June 30, 2024.Accounts Receivable: $932,000 as of June 30, 2024.Inventory: $433,000 net of reserves as of June 30, 2024.GuruFocus has detected 5 Warning Signs with BKYI.For the complete transcript of the earnings call, please refer to the full earnings call transcript.BIO-key International Inc  has launched its Passkey:YOU product, which has received favorable initial customer reactions and interest from Fortune 500 prospects.BIO-key's solutions are now available on the Amazon Web Services marketplace, potentially increasing global reach and recurring revenues.","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"BIO":"Bio Rad实验室","AMZN":"亚马逊","BKYI":"BIO-key International, Inc."},"translate_title":"BIO-key International Inc(BKYI)2024年第二季度收益看涨期权亮点：应对挑战...","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BIO":1,"BKYI":1,"AMZN":0.9},"content_text":"Revenue: $1.1 million in Q2 2024, down from $1.9 million in Q2 2023.\nGross Margin: Improved to 77% in Q2 2024 from 69% in Q2 2023.\nNet Loss: $1.7 million, or $1 per share, in Q2 2024, improved from $2.6 million, or $4.71 per share, in Q2 2023.\nOperating Expenses: Reduced by $168,000 in Q2 2024 compared to Q2 2023.\nCash and Cash Equivalents: $1.3 million as of June 30, 2024.\nAccounts Receivable: $932,000 as of June 30, 2024.\nInventory: $433,000 net of reserves as of June 30, 2024.\n\n\nWarning! GuruFocus has detected 5 Warning Signs with BKYI.\n\nRelease Date: August 15, 2024\nFor the complete transcript of the earnings call, please refer to the full earnings call transcript.\n Positive Points \n\nBIO-key International Inc (NASDAQ:BKYI) has launched its Passkey:YOU product, which has received favorable initial customer reactions and interest from Fortune 500 prospects.\nThe company has expanded its PortalGuard deployments with notable clients such as the University of Iowa Hospital and Dayton Children's Hospital.\nBIO-key's solutions are now available on the Amazon Web Services marketplace, potentially increasing global reach and recurring revenues.\nThe company received the Global Infrasec Hot Company Multifactor Authentication Award from Cyber Defense magazine, highlighting the strength of its solutions.\nBIO-key is focusing on high-margin, annual recurring revenues, which have solid potential to build on its base moving forward.\n\n Negative Points \n\nQ2 2024 revenue of $1.1 million fell below the year-ago revenue of approximately $1.9 million, primarily due to delays in software license contracts.\nThe company experienced lower services revenue related to customizations and upgrades for a large customer project that did not occur in Q2 2024.\nA large recurring maintenance contract did not renew in Q1 2024, negatively impacting the current year's top-line revenue.\nBIO-key's financial performance remains variable due to the size and timing of customer contracts and commitments.\nThe company has faced significant delays in large projects in Africa, impacting its financial results and leading to a write-down of over $3 million in inventory.\n\n Q & A Highlights \nQ: Can you explain why reported revenue hasn't picked up substantially despite efforts to grow the recurring revenue base and channel partner programs? A: Michael DePasquale, CEO, explained that the key issue is closing more opportunities in their pipeline. The company is pursuing larger sales with higher-profile customers, which have longer sales cycles. They are focusing on increasing the number of opportunities, shortening sales cycles, and improving close ratios. Additionally, they are enhancing direct selling efforts and leveraging new resources to target enterprise-focused opportunities.\nQ: Is the recent Amazon marketplace announcement a continuation of your previous acceptance into Amazon's AWS independent software vendor program? A: Yes, Michael DePasquale confirmed that it is a continuation. Initially, they were accepted as a vendor, and now they have developed their storefront to be live on the marketplace. This allows Amazon customers to easily acquire BIO-Key solutions.\nQ: Do you expect revenue from the Amazon channel to start this year? A: Michael DePasquale affirmed that they expect revenue from the Amazon channel to start this year. The company is live on the marketplace, and marketing and promotion efforts will begin at the end of the current quarter and into October.\nQ: What does your outlook commentary mean regarding sequential growth on a full-year basis? A: Michael DePasquale clarified that they expect to grow their business year-over-year and anticipate higher revenues in the second half of the year compared to the first half. Despite a challenging quarter, they are confident in achieving year-over-year revenue growth.\nQ: Are the two large Africa contracts still viable, or have they been canceled? A: Michael DePasquale stated that the projects are still alive, but there have been significant delays due to political and economic issues in Nigeria. They remain optimistic about selling equipment in the market and are exploring other opportunities in the payment space and financial services in Africa.\nFor the complete transcript of the earnings call, please refer to the full earnings call transcript.This article first appeared on \nGuruFocus.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2474785064"}